Literature DB >> 20065560

Medial pancreatectomy for a neuroendocrine tumor invading the splenic artery and vein.

Abdelmounaim Ait-Ali1, Ibrahima Sall, Hakim El-Kaoui, Sidi Mohammed Bouchentouf, Abderrahmane El-Hjouji, Fadwa Rouibaa, Ahmed Benkirane, Ahmed Bounaim, Aziz Zentar, Khalid Sair.   

Abstract

CONTEXT: Pancreatic tumors in the midportion have traditionally been treated by an extended right or left pancreatectomy. A medial or central pancreatectomy is an alternative technique for benign or low-grade malignant neoplasms located to the left of the gastroduodenal artery and close to the splenomesenteric confluence. CASE REPORT: A 38-year-old woman with no previous surgical history presented with epigastric abdominal pain. A computed tomography scan showed a 4 cm heterogeneous lesion within the pancreatic body. This tumor invaded the splenic artery and vein. There was no postoperative diabetes mellitus or exocrine insufficiency. The patient continues to be well after a 10-month follow-up without pancreatic insufficiency or local recurrence, and CT has demonstrated splenic perfusion by the collateral vessels.
CONCLUSION: We believe that a medial or central pancreatectomy may be a safe procedure where there is involvement of the large splenic vessels by a low grade malignant pancreatic tumor and that a systematic splenectomy is not justified.

Entities:  

Mesh:

Year:  2010        PMID: 20065560

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  2 in total

1.  Pancreatic endocrine tumors with major vascular abutment, involvement, or encasement and indication for resection.

Authors:  Jeffrey A Norton; Edmund J Harris; Yijun Chen; Brendan C Visser; George A Poultsides; Pamela C Kunz; George A Fisher; Robert T Jensen
Journal:  Arch Surg       Date:  2011-06

2.  Pancreatic neuroendocrine tumor with splenic vein tumor thrombus: A case report.

Authors:  Rodrigo A Rodriguez; Heidi Overton; Katherine T Morris
Journal:  Int J Surg Case Rep       Date:  2014-11-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.